https://biotechmorning.com/news/fda-bespoke-gene-therapy-framework-2 Biotech Morning en 2026-07-24T14:28:25.309Z The FDA Just Opened the Door to Medicines Built for One Person https://biotechmorning.com/news/eplontersen-attr-cardiomyopathy-trial-failure Biotech Morning en 2026-07-24T14:27:32.461Z The Heart Drug That Should Have Worked — But Didn't https://biotechmorning.com/news/lilly-retatrutide-obesity-cardiovascular-miss Biotech Morning en 2026-07-24T14:26:39.264Z Lilly's Next Obesity Blockbuster Just Hit a Wall It Didn't See Coming https://biotechmorning.com/news/sclc-ris-rez-survival-benefit Biotech Morning en 2026-07-24T14:25:43.947Z The Cancer That Broke Every Drug That Tried. Until Now. https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-elevidys-2 Biotech Morning en 2026-07-24T14:24:53.667Z Sarepta's Worst Week: A Black Box, 500 Pink Slips, and a Stock in Crisis https://biotechmorning.com/news/car-t-solid-tumor-breakthrough-china-approval Biotech Morning en 2026-07-24T14:23:59.896Z CAR-T Just Broke Through the Wall That Stopped It for a Decade https://biotechmorning.com/news/novartis-myricx-billion-dollar-adc-deal Biotech Morning en 2026-07-24T14:23:12.061Z Novartis Just Dropped $1.1 Billion on a Company With Zero Approved Drugs https://biotechmorning.com/news/crispr-casgevy-approved-toddlers-sickle-cell Biotech Morning en 2026-07-24T14:22:14.185Z CRISPR Just Got Cleared for Toddlers. Yes, Toddlers. https://biotechmorning.com/news/pfizer-seagen-sigvotatug-vedotin-nsclc-failure Biotech Morning en 2026-07-24T14:21:19.827Z Pfizer Spent $43 Billion on an ADC Empire. One of Its Crown Jewels Just Cracked. https://biotechmorning.com/news/abbvie-apogee-therapeutics-acquisition-10-billion-2 Biotech Morning en 2026-07-24T14:20:29.867Z AbbVie Just Bet $10.9 Billion on a Company That Didn't Exist Three Years Ago https://biotechmorning.com/news/nih-5-billion-ai-chronic-disease-initiative Biotech Morning en 2026-07-23T14:24:42.427Z The $5 Billion Bet That AI Can Crack Chronic Disease https://biotechmorning.com/news/congress-fda-animal-testing-modernization-act Biotech Morning en 2026-07-23T14:23:53.330Z Congress Just Told the FDA to Stop Requiring Lab Rats https://biotechmorning.com/news/cancer-weapon-switched-sides-oblenio-bio Biotech Morning en 2026-07-23T14:23:03.115Z Cancer's Favorite Weapon Just Switched Sides https://biotechmorning.com/news/ai-built-proteins-molecular-sensors Biotech Morning en 2026-07-23T14:22:02.682Z These AI-Built Proteins Sit Quietly Until They Smell Trouble https://biotechmorning.com/news/pfizer-talzenna-xtandi-priority-review-prostate-cancer Biotech Morning en 2026-07-23T14:21:04.211Z Pfizer's Prostate Cancer Combo Just Got the FDA's Fast Lane https://biotechmorning.com/news/zepbound-cheaper-single-dose-vials-2 Biotech Morning en 2026-07-23T14:20:16.130Z Zepbound Just Got a Secret Back Door to Cheaper Prices https://biotechmorning.com/news/roche-kills-lupus-tce-doubles-down-autoimmune Biotech Morning en 2026-07-23T14:19:26.053Z Roche Just Killed Its Lupus Weapon, Then Said "We're Not Done" https://biotechmorning.com/news/senate-bill-biologic-patent-thickets Biotech Morning en 2026-07-23T14:18:34.571Z The Senate Just Declared War on Pharma's Favorite Legal Trick https://biotechmorning.com/news/fifth-ros1-lung-cancer-drug-fda-approval-zidesamtinib Biotech Morning en 2026-07-23T14:17:41.114Z The Fifth Drug for a Cancer That Hits 2% of Lung Patients